Reprocell Stock Net Income
| 6RC Stock | EUR 0.57 0.00 0.00% |
As of the 5th of February, REPROCELL holds the Market Risk Adjusted Performance of (0.10), coefficient of variation of (69,363), and Risk Adjusted Performance of 0.0083. REPROCELL technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices. Please check REPROCELL treynor ratio, value at risk, and the relationship between the information ratio and maximum drawdown to decide if REPROCELL is priced more or less accurately, providing market reflects its current price of 0.57 per share.
REPROCELL Total Revenue |
|
Market Capitalization 131.4 M | Enterprise Value Revenue 3.5705 |
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 118.7 M | 124.7 M | |
| Net Income | 118.7 M | 124.7 M |
REPROCELL | Net Income |
Analyzing REPROCELL's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing REPROCELL's current valuation and future prospects.
Latest REPROCELL's Net Income Growth Pattern
Below is the plot of the Net Income of REPROCELL over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in REPROCELL financial statement analysis. It represents the amount of money remaining after all of REPROCELL operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is REPROCELL's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in REPROCELL's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 103.25 M | 10 Years Trend |
|
Net Income |
| Timeline |
REPROCELL Net Income Regression Statistics
| Arithmetic Mean | (679,375,701) | |
| Geometric Mean | 486,320,543 | |
| Coefficient Of Variation | (83.99) | |
| Mean Deviation | 422,238,705 | |
| Median | (911,664,000) | |
| Standard Deviation | 570,628,038 | |
| Sample Variance | 325616.4T | |
| Range | 2.3B | |
| R-Value | 0.67 | |
| Mean Square Error | 192489.1T | |
| R-Squared | 0.45 | |
| Significance | 0 | |
| Slope | 75,448,412 | |
| Total Sum of Squares | 5209861.7T |
REPROCELL Net Income History
REPROCELL 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to REPROCELL's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of REPROCELL.
| 11/07/2025 |
| 02/05/2026 |
If you would invest 0.00 in REPROCELL on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding REPROCELL or generate 0.0% return on investment in REPROCELL over 90 days. REPROCELL is related to or competes with Japan Asia, PennyMac Mortgage, Safety Insurance, ZURICH INSURANCE, REINET INVESTMENTS, CapitaLand Investment, and Reinsurance Group. REPROCELL is entity of Germany. It is traded as Stock on BE exchange. More
REPROCELL Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure REPROCELL's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess REPROCELL upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 119.21 | |||
| Value At Risk | (4.41) | |||
| Potential Upside | 3.03 |
REPROCELL Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for REPROCELL's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as REPROCELL's standard deviation. In reality, there are many statistical measures that can use REPROCELL historical prices to predict the future REPROCELL's volatility.| Risk Adjusted Performance | 0.0083 | |||
| Jensen Alpha | (0.04) | |||
| Total Risk Alpha | (0.85) | |||
| Treynor Ratio | (0.11) |
REPROCELL February 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0083 | |||
| Market Risk Adjusted Performance | (0.10) | |||
| Mean Deviation | 2.99 | |||
| Coefficient Of Variation | (69,363) | |||
| Standard Deviation | 11.09 | |||
| Variance | 122.9 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0.04) | |||
| Total Risk Alpha | (0.85) | |||
| Treynor Ratio | (0.11) | |||
| Maximum Drawdown | 119.21 | |||
| Value At Risk | (4.41) | |||
| Potential Upside | 3.03 | |||
| Skewness | 4.38 | |||
| Kurtosis | 39.34 |
REPROCELL Backtested Returns
At this point, REPROCELL is out of control. REPROCELL maintains Sharpe Ratio (i.e., Efficiency) of close to zero, which implies the firm had a close to zero % return per unit of standard deviation over the last 3 months. We have found eighteen technical indicators for REPROCELL, which you can use to evaluate the volatility of the company. Please check REPROCELL's Risk Adjusted Performance of 0.0083, market risk adjusted performance of (0.10), and Coefficient Of Variation of (69,363) to confirm if the risk estimate we provide is consistent with the expected return of 0.11%. The company holds a Beta of 0.23, which implies not very significant fluctuations relative to the market. As returns on the market increase, REPROCELL's returns are expected to increase less than the market. However, during the bear market, the loss of holding REPROCELL is expected to be smaller as well. REPROCELL currently holds a risk of 11.72%. Please check REPROCELL variance, jensen alpha, value at risk, as well as the relationship between the information ratio and maximum drawdown , to decide if REPROCELL will be following its historical price patterns.
Auto-correlation | 0.31 |
Below average predictability
REPROCELL has below average predictability. Overlapping area represents the amount of predictability between REPROCELL time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of REPROCELL price movement. The serial correlation of 0.31 indicates that nearly 31.0% of current REPROCELL price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.31 | |
| Spearman Rank Test | -0.65 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
REPROCELL Net Interest Income
Net Interest Income |
|
Based on the recorded statements, REPROCELL reported net income of 103.25 M. This is much higher than that of the Metals & Mining sector and significantly higher than that of the Materials industry. The net income for all Germany stocks is notably lower than that of the firm.
REPROCELL Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses REPROCELL's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of REPROCELL could also be used in its relative valuation, which is a method of valuing REPROCELL by comparing valuation metrics of similar companies.REPROCELL is currently under evaluation in net income category among its peers.
REPROCELL Fundamentals
| Current Valuation | 51.1 M | ||||
| Price To Book | 1.14 X | ||||
| Price To Sales | 3.77 X | ||||
| Revenue | 2.98 B | ||||
| EBITDA | (513.85 M) | ||||
| Net Income | 103.25 M | ||||
| Total Debt | 685.81 M | ||||
| Cash Flow From Operations | 6.29 M | ||||
| Market Capitalization | 131.36 M | ||||
| Total Asset | 9.67 B | ||||
| Retained Earnings | 58.29 M | ||||
| Working Capital | 4.26 B | ||||
| Net Asset | 9.67 B |
About REPROCELL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze REPROCELL's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of REPROCELL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of REPROCELL based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in REPROCELL Stock
REPROCELL financial ratios help investors to determine whether REPROCELL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in REPROCELL with respect to the benefits of owning REPROCELL security.